Formula Growth’s Teladoc Health TDOC Stock Holding History

Formula Growth’s Portfolio TDOC Stock Details TDOC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-219,353	Closed	-$1.75M	–	140
2025 Q1	$1.75M	Buy	+219,353	New	+$2.22M	0.71%	59
2022 Q3	–	Sell	-8,438	Closed	-$280K	–	141
2022 Q2	$280K	Hold	8,438	–	–	0.08%	126
2022 Q1	$609K	Hold	8,438	–	–	0.11%	132
2021 Q4	$775K	Hold	8,438	–	–	0.14%	122
2021 Q3	$1.07M	Hold	8,438	–	–	0.15%	129
2021 Q2	$1.4M	Hold	8,438	–	–	0.19%	122
2021 Q1	$1.53M	Hold	8,438	–	–	0.22%	124
2020 Q4	$1.69M	Hold	8,438	–	–	0.28%	94
2020 Q3	$1.85M	Sell	8,438 -3,700	-30%	-$784K	0.35%	83
2020 Q2	$2.32M	Sell	12,138 -12,800	-51%	-$2.24M	0.39%	71
2020 Q1	$3.87M	Sell	24,938 -12,780	-34%	-$1.49M	0.74%	38
2019 Q4	$3.16M	Hold	37,718	–	–	0.4%	68
2019 Q3	$2.55M	Hold	37,718	–	–	0.38%	71
2019 Q2	$2.5M	Hold	37,718	–	–	0.36%	69
2019 Q1	$2.1M	Buy	37,718 +5,000	+15%	+$305K	0.3%	76
2018 Q4	$1.62M	Sell	32,718 -5,000	-13%	-$306K	0.27%	80
2018 Q3	$3.26M	Sell	37,718 -7,600	-17%	-$542K	0.37%	56
2018 Q2	$2.63M	Sell	45,318 -3,775	-8%	-$184K	0.29%	74
2018 Q1	$1.98M	Buy	49,093 +1,000	+2%	+$37.7K	0.23%	90
2017 Q4	$1.68M	Hold	48,093	–	–	0.22%	92
2017 Q3	$1.59M	Sell	48,093 -5,000	-9%	-$164K	0.25%	98
2017 Q2	$1.84M	Sell	53,093 -40,000	-43%	-$1.17M	0.32%	86
2017 Q1	$2.33M	Buy	93,093 +34,993	+60%	+$728K	0.49%	58
2016 Q4	$959K	Hold	58,100	–	–	0.22%	106
2016 Q3	$1.06M	Buy	58,100 +45,400	+357%	+$796K	0.24%	116
2016 Q2	$203K	Buy	+12,700	New	+$148K	0.05%	147

Other funds holding TDOC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

MRCP

Maple Rock Capital Partners Toronto, Ontario, Canada $5.1B AUM 214.22% 1-Year Est. Return

Formula Growth's TDOC Position: Q2 2025 in Review

Formula Growth sold out of Teladoc Health (TDOC) in Q2 2025, closing a stake of 219,353 shares — an estimated $1.75M sold.

Formula Growth first reported a position in TDOC in Q2 2016 and held it in 26 quarters. The position peaked at $3.87M in Q1 2020. 359 funds tracked by Wall St. Rank hold TDOC as of Q2 2025.

Formula Growth reported no remaining Teladoc Health position as of Q2 2025 after selling out during the quarter.
Formula Growth sold 219,353 Teladoc Health shares in Q2 2025, an estimated $1.75M.
Formula Growth first reported a position in Teladoc Health in Q2 2016 and held it in 26 quarters.
Formula Growth's Teladoc Health position peaked at $3.87M in Q1 2020.
359 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2025.

Based on Formula Growth's 13F filing for Q2 2025, filed 13 Aug 2025.